‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents

THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 1959-02, Vol.183 (4658), p.399-400
Hauptverfasser: BARDOS, THOMAS J., PAPANASTASSIOU, ZINON B., SEGALOFF, ALBERT, AMBRUS, JULIAN L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 400
container_issue 4658
container_start_page 399
container_title Nature (London)
container_volume 183
creator BARDOS, THOMAS J.
PAPANASTASSIOU, ZINON B.
SEGALOFF, ALBERT
AMBRUS, JULIAN L.
description THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences.
doi_str_mv 10.1038/183399a0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_82293953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>82293953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</originalsourceid><addsrcrecordid>eNplkM1OwkAUhSdGI4gmPoHpysBidP7aacOK4G9CcCGum2l7C8VpB2faGHY8hr4eT2IJGBcubs7ifvmScxC6pOSGEh7e0pDzKFLkCHWpkAEWQSiPUZcQFmIS8qCDzpxbEkJ8KsUp6lAecCZ50EV6u_m6a5T2RlWt5qYqXO22m--hN9Lva-1NcT8pHO5DvVhrqIqyyMxgtTCuPWsGOFU2UaWqwQ095U3h03sFW4DzTL4zFnjWlKax3mgOVe3O0UmutIOLQ_bQ28P9bPyEJy-Pz-PRBKec-jXOEuZTESUUhJ_6IfVVJgnliqpcCAEilAHPpEyziAUsSJjMkohLkEQInlOa8B663ntX1nw04Oq4LFwKWqsKTOPikLGIRz5vwf4eTK1xzkIer2xRKruOKYl3y8a_y7bo1cHZJCVkf-BhyhYY7AHXvqo52HjZNq_anv9lP6CCgRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>82293953</pqid></control><display><type>article</type><title>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</title><source>MEDLINE</source><source>Nature</source><source>Springer Nature - Complete Springer Journals</source><creator>BARDOS, THOMAS J. ; PAPANASTASSIOU, ZINON B. ; SEGALOFF, ALBERT ; AMBRUS, JULIAN L.</creator><creatorcontrib>BARDOS, THOMAS J. ; PAPANASTASSIOU, ZINON B. ; SEGALOFF, ALBERT ; AMBRUS, JULIAN L.</creatorcontrib><description>THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences.</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/183399a0</identifier><identifier>PMID: 13632736</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Antineoplastic Agents ; Carbamates ; Esters ; Humanities and Social Sciences ; Humans ; letter ; multidisciplinary ; Neoplasms ; Old Medline ; Science ; Science (multidisciplinary)</subject><ispartof>Nature (London), 1959-02, Vol.183 (4658), p.399-400</ispartof><rights>Springer Nature Limited 1959</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</citedby><cites>FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/183399a0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/183399a0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/13632736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BARDOS, THOMAS J.</creatorcontrib><creatorcontrib>PAPANASTASSIOU, ZINON B.</creatorcontrib><creatorcontrib>SEGALOFF, ALBERT</creatorcontrib><creatorcontrib>AMBRUS, JULIAN L.</creatorcontrib><title>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</title><title>Nature (London)</title><addtitle>Nature</addtitle><addtitle>Nature</addtitle><description>THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences.</description><subject>Antineoplastic Agents</subject><subject>Carbamates</subject><subject>Esters</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>letter</subject><subject>multidisciplinary</subject><subject>Neoplasms</subject><subject>Old Medline</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1959</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkM1OwkAUhSdGI4gmPoHpysBidP7aacOK4G9CcCGum2l7C8VpB2faGHY8hr4eT2IJGBcubs7ifvmScxC6pOSGEh7e0pDzKFLkCHWpkAEWQSiPUZcQFmIS8qCDzpxbEkJ8KsUp6lAecCZ50EV6u_m6a5T2RlWt5qYqXO22m--hN9Lva-1NcT8pHO5DvVhrqIqyyMxgtTCuPWsGOFU2UaWqwQ095U3h03sFW4DzTL4zFnjWlKax3mgOVe3O0UmutIOLQ_bQ28P9bPyEJy-Pz-PRBKec-jXOEuZTESUUhJ_6IfVVJgnliqpcCAEilAHPpEyziAUsSJjMkohLkEQInlOa8B663ntX1nw04Oq4LFwKWqsKTOPikLGIRz5vwf4eTK1xzkIer2xRKruOKYl3y8a_y7bo1cHZJCVkf-BhyhYY7AHXvqo52HjZNq_anv9lP6CCgRA</recordid><startdate>19590207</startdate><enddate>19590207</enddate><creator>BARDOS, THOMAS J.</creator><creator>PAPANASTASSIOU, ZINON B.</creator><creator>SEGALOFF, ALBERT</creator><creator>AMBRUS, JULIAN L.</creator><general>Nature Publishing Group UK</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19590207</creationdate><title>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</title><author>BARDOS, THOMAS J. ; PAPANASTASSIOU, ZINON B. ; SEGALOFF, ALBERT ; AMBRUS, JULIAN L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1959</creationdate><topic>Antineoplastic Agents</topic><topic>Carbamates</topic><topic>Esters</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>letter</topic><topic>multidisciplinary</topic><topic>Neoplasms</topic><topic>Old Medline</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BARDOS, THOMAS J.</creatorcontrib><creatorcontrib>PAPANASTASSIOU, ZINON B.</creatorcontrib><creatorcontrib>SEGALOFF, ALBERT</creatorcontrib><creatorcontrib>AMBRUS, JULIAN L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BARDOS, THOMAS J.</au><au>PAPANASTASSIOU, ZINON B.</au><au>SEGALOFF, ALBERT</au><au>AMBRUS, JULIAN L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</atitle><jtitle>Nature (London)</jtitle><stitle>Nature</stitle><addtitle>Nature</addtitle><date>1959-02-07</date><risdate>1959</risdate><volume>183</volume><issue>4658</issue><spage>399</spage><epage>400</epage><pages>399-400</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><abstract>THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>13632736</pmid><doi>10.1038/183399a0</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-0836
ispartof Nature (London), 1959-02, Vol.183 (4658), p.399-400
issn 0028-0836
1476-4687
language eng
recordid cdi_proquest_miscellaneous_82293953
source MEDLINE; Nature; Springer Nature - Complete Springer Journals
subjects Antineoplastic Agents
Carbamates
Esters
Humanities and Social Sciences
Humans
letter
multidisciplinary
Neoplasms
Old Medline
Science
Science (multidisciplinary)
title ‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A21%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%98Dual%20Antagonists%E2%80%99;%20Alkyl%20N-(bis-(ethylenimido)phosphoro)-carbamates;%20a%20New%20Series%20of%20Anti-Tumour%20Agents&rft.jtitle=Nature%20(London)&rft.au=BARDOS,%20THOMAS%20J.&rft.date=1959-02-07&rft.volume=183&rft.issue=4658&rft.spage=399&rft.epage=400&rft.pages=399-400&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/10.1038/183399a0&rft_dat=%3Cproquest_cross%3E82293953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=82293953&rft_id=info:pmid/13632736&rfr_iscdi=true